Pharmacists Welcome Medicaid AMP Rule Revisions

Law360, New York (September 7, 2010, 2:58 PM EDT) -- Pharmacy industry groups are cheering the Centers for Medicare & Medicaid Services' proposed changes to a federal rule setting pharmacies' reimbursement rates for generic Medicaid prescriptions, portions of which have been frozen by a preliminary injunction since 2007.

Under a proposal published in Friday's Federal Register, CMS is planning to withdraw several provisions from what is known as the Medicaid average manufacturer price rules that determine the AMP and federal upper limits on prices for multiple-source drugs, as well as a revised definition of “multiple-source drugs.”...
To view the full article, register now.